Biotech investor Thilo Schroeder of Nextech Invest shares his take on biotech and discusses portfolio companies Revolution Medicines, Tubulis, and Circle Pharma
He describes the history of Nextech, including being an early investor in Blueprint Medicines and Peloton, and discusses the importance of investing in companies that have a wide moat to protect from today's fierce global competition.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.